A retrospective observational study of safety profiles of non-small cell lung cancer patients treated with pemetrexed plus carboplatin.

Trial Profile

A retrospective observational study of safety profiles of non-small cell lung cancer patients treated with pemetrexed plus carboplatin.

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Jun 2017

At a glance

  • Drugs Carboplatin (Primary) ; Pemetrexed (Primary)
  • Indications Non-small cell lung cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 15 Jun 2017 New trial record
    • 01 May 2017 Results published in the Current Medical Research and Opinion
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top